Long Term Follow up for the Detection of Delayed Adverse Events in Cal-1 Recipients

Clinical trial NCT02390297 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02390297
Sponsor: Calimmune, Inc.
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

HIV-1 Infection Receipt of Cal-1 Modified Hematopoietic Cellular Products

Start date: 2015-04-01
Primary completion: 2031-10-01
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.